At the European Academy of Neurology Congress in Helsinki, researchers unveiled a ground breaking blood test that could revolutionize Alzheimer’s disease management by identifying
You must be a Free member to access this content.
Two innovative Alzheimer’s drugs, Donanemab and Lecanemab, have been rejected by the NHS due to their exorbitant cost and limited impact. These are the first treatments to slow the disease, potentially extending
You must be a Free member to access this content.
The UK Government's Spending Review, announced on June 11, 2025, by Chancellor Rachel Reeves, outlined spending and investment plans through 2029 - 30, addressing key public
You must be a Free member to access this content.
On June 1, 2025, Northamptonshire Fire and Rescue Service launched a campaign offering free home fire safety visits tailored for individuals with dementia, aiming to enhance
You must be a Free member to access this content.
Alzheimer’s disease is often seen as a brain problem, but new evidence shows it can affect other body parts too. Scientists at Baylor College of Medicine
You must be a Free member to access this content.